Loading
NASDAQHealthcareBiotechnology
Latest quote
$1.43
−$0.07 · -4.67%
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Previous close
$1.43
−$0.07 · -4.67%
After-hours
$1.4006
−$0.0294 · -2.06%
Oct 8, 7:56 PM ET
Regular session · ET · Market data may be delayed.
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Day range
Current $1.43
52-week range
Current $1.43
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
52
Fair Value
Sentiment
58
Mixed
Risk
70
High Risk
Momentum
31
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Day range
Current $1.43
52-week range
Current $1.43
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CAD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 15.32M CAD | 24.52M CAD | 24.52M CAD | 20.67M CAD | 19.36M CAD |
| Cost of goods sold | 6.31M CAD | 10.97M CAD | 12.47M CAD | 9.1M CAD | 8.38M CAD |
| Gross profit | 9.01M CAD | 13.55M CAD | 12.05M CAD | 11.56M CAD | 10.98M CAD |
| Research and development | 4.86M CAD | 4.94M CAD | 4.04M CAD | 14.1M CAD | 7.66M CAD |
| Selling, general, and administrative | 18.86M CAD | 19.03M CAD | 19.14M CAD | 18.99M CAD | 18.06M CAD |
| Operating expenses | 23.72M CAD | 25.74M CAD | 25.82M CAD | 37.17M CAD | 27.66M CAD |
| Interest income | — | — | 23K CAD | 122K CAD | 279K CAD |
| Interest expense | — | 9.91K CAD | 19K CAD | 30K CAD | 85K CAD |
| Depreciation and amortization | 1.58M CAD | 5.12M CAD | 5.74M CAD | 6.69M CAD | 3.77M CAD |
| Operating income | −14.71M CAD | −12.2M CAD | −13.76M CAD | −25.61M CAD | −16.67M CAD |
| Net income | −13.74M CAD | −30.23M CAD | −26.12M CAD | −26.56M CAD | −16.71M CAD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$5.00
249.65% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Nov 23, 2020 | 1:5 | — | — |
Stock split | Jan 3, 2017 | 1:3 | — | — |
Stock split | Sep 2, 2016 | 1:3 | — | — |
Stock split | May 30, 2013 | 4:1 | — | — |
Stock split | Apr 12, 2013 | 4:1 | — | — |
Stock split | Sep 13, 2011 | 1:10 | — | — |
Effective Nov 23, 2020
1:5
Effective Jan 3, 2017
1:3
Effective Sep 2, 2016
1:3
Effective May 30, 2013
4:1
Effective Apr 12, 2013
4:1
Effective Sep 13, 2011
1:10
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
